Rising stock prices and some positive clinical trial results have been encouraging recent signs for the biotech industry. In addition, public offerings were up, leading a number of observers to believe that the IPO window may be opening. Do you believe that the sector’s future has started to look brighter?

Poll Question:
Do you think the bioindustry has begun to turn the corner in terms of financing opportunities?

Yes
28

No
7

Too early to tell
23

Undecided
2

Previous articleGenoLogics and CLC bio to Provide Data-Management and Analysis Solution for Next-Gen Sequencing
Next articleSanofi-Aventis Inks $350M Deal for Wellstat’s Phase II Therapy for Type 2 Diabetes